Trelagliptin is an orally active dipeptidyl peptidase (DPP)-4 inhibitor approved in Japan for the treatment of…
Zerpidio (Serplulimab) sold under the brand name 汉斯状 in china. Serplulimab, a recombinant humanised anti-PD-1 monoclonal…
BRUKINSA (Zanubrutinib) sold under the brand name 百悦泽 in china, is a BTK Inhibitor used to…
Ryzneuta® (Efbemalenograstim alfa-vuxw), sold under the brand name 亿立舒® in china, is a leukocyte growth factor used…
Tofidence® (Tocilizumab-bavi) sold under the brand name 施瑞立® in china, is a monoclonal antibody that binds to interlukin-6 receptors and…
Avzivi® (Bevacizumab-tnjn) sold under the brand name POBEVCY (普贝希) in China, is a humanized monoclonal antibody…
Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia (AML) in people with specific mutations…
Larotrectinib is a treatment for solid cancers that have a neurotrophic tyrosine receptor kinase (NTRK) gene change.…